Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07166939 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

45th Multicenter Airway Research Collaboration

Study acronym: MARC-45
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Primary and study completion dates: Jun 2026 to Jun 2027 · Start date changed from estimate of Sep 2025 to Nov 7, 2025 · Study description shortened, about 6 words · 2 morev3 Show 5 more changesShow less
    • Primary and study completion dates: Jun 2026 to Jun 2027
    • Start date changed from estimate of Sep 2025 to Nov 7, 2025
    • Study description shortened, about 6 words
    • Site details revised
    • Eligibility criteria shortened, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  2. Study description expanded, about 4 wordsv2 See this version in full on ClinicalTrials.gov ↗
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).
Trial Details
NCT Number NCT07166939
Lead Sponsor Massachusetts General Hospital
Conditions Asthma Acute, Asthma Exacerbation, Asthma, Asthma Control Level
Enrollment 1,860 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov